13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q4 2025. See the latest, Q3 2026 →
Reported value
$4.49B
+11% on the quarter before
Positions
62
28 new, 31 sold out
Top 10
52.3%
of the value
Est. gain
+$316.2M
on stocks held all quarter
Est. return
+14.2%
on those stocks since Q3 2025
Positions as of Dec 31, 2025, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.
Largest buys
Since Q3 2025, sized at quarter-end prices.
- Select Sector SPDR Tr~$301.0MNew, 0.0% → 6.7% of the portfolio+5,495,600 shares
- Invesco Exchange Traded Fd T~$224.9MNew, 0.0% → 5.0% of the portfolio+1,173,925 shares
- Ishares IncCALL~$134.3MNew, 0.0% → 3.0% of the portfolio+4,228,000 underlying
- Ishares Inc~$112.9MNew, 0.0% → 2.5% of the portfolio+3,552,575 shares
- Alphabet~$88.5MAdded, 0.6% → 2.7% of the portfolio+282,800 shares
- Sea~$85.5MAdded, 1.2% → 2.7% of the portfolio+669,920 shares
- Alcoa Corp~$73.1MNew, 0.0% → 1.6% of the portfolio+1,376,050 shares
- Entegris~$71.1MNew, 0.0% → 1.6% of the portfolio+844,160 shares
- Amazon~$69.4MAdded, 2.4% → 3.8% of the portfolio+300,870 shares
- Lattice Semiconductor~$68.1MNew, 0.0% → 1.5% of the portfolio+925,970 shares
Largest sells
Since Q3 2025, sized at quarter-end prices.
- Teva Pharmaceutical Inds Ltd~$334.5MCut, 8.3% → 4.1% of the portfolio−10,719,065 shares
- Insmed Inc~$163.9MCut, 8.6% → 5.7% of the portfolio−941,683 shares
- Natera Inc~$161.1MCut, 12.7% → 12.8% of the portfolio−703,175 shares
- Verona Pharma Plc~$106.9MSold out, 2.6% → 0.0% of the portfolio−1,002,080 shares
- TSMC~$67.5MCut, 5.3% → 3.7% of the portfolio−222,000 shares
- Meta~$55.9MSold out, 1.4% → 0.0% of the portfolio−76,100 shares
- Ishares Tr~$54.6MCut, 2.5% → 1.1% of the portfolio−997,500 shares
- Carpenter Technology Corp~$54.0MSold out, 1.3% → 0.0% of the portfolio−220,035 shares
- Citigroup Inc~$52.3MSold out, 1.3% → 0.0% of the portfolio−514,850 shares
- Twilio~$51.3MSold out, 1.3% → 0.0% of the portfolio−512,800 shares
Holdings
As of Dec 31, 2025; changes in shares since Sep 30, 2025.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Natera IncCOM · shares −22% · price +42.3% | 12.8% | $575.3M | +$171.1M | ||||||
| Select Sector SPDR TrSTATE STREET FIN · shares New | 6.7% | $301.0M | — | ||||||
| Insmed IncCOM PAR $.01 · shares −39% · price +20.9% | 5.7% | $257.9M | +$44.5M | ||||||
| Invesco Exchange Traded Fd TS&P500 EQL WGT · shares New | 5.0% | $224.9M | — | ||||||
| Teva Pharmaceutical Inds LtdSPONSORED ADS · shares −65% · price +54.5% | 4.1% | $183.4M | +$64.7M | ||||||
| Woodward IncCOM · shares −6.6% · price +19.6% | 4.0% | $178.7M | +$29.3M | ||||||
| AmazonCOM · shares +69% · price +5.1% | 3.8% | $170.3M | +$4.9M | ||||||
| TSMCSPONSORED ADS · shares −29% · price +8.8% | 3.7% | $165.0M | +$13.4M | ||||||
| Coupang IncCL A · shares +46% · price −26.7% | 3.6% | $159.8M | −$39.9M | ||||||
| Ishares IncCALLMSCI BRAZIL ETF · shares New | 3.0% | $134.3M | — | ||||||
| AlphabetCAP STK CL A · shares +277% · price +28.8% | 2.7% | $120.5M | +$7.1M | ||||||
| SeaSPONSORD ADS · shares +244% · price −28.6% | 2.7% | $120.4M | −$14.0M | ||||||
| Ishares IncMSCI BRAZIL ETF · shares New | 2.5% | $112.9M | — | ||||||
| Newamsterdam Pharma CompanyORDINARY SHARES · shares +60% · price +23.3% | 2.4% | $107.7M | +$12.8M | ||||||
| MercadoLibreCOM · shares −19% · price −13.8% | 2.1% | $95.0M | −$15.2M | ||||||
| Bbb Foods IncCL A COM · shares +126% · price +23.8% | 2.0% | $89.3M | +$7.6M | ||||||
| Restaurant Brands Intl IncCOM · shares +6.9% · price +6.4% | 1.8% | $82.5M | +$4.6M | ||||||
| Cogent Biosciences IncCOM · shares +109% · price +147.3% | 1.8% | $78.7M | +$22.4M | ||||||
| Alcoa CorpCOM · shares New | 1.6% | $73.1M | — | ||||||
| EntegrisCOM · shares New | 1.6% | $71.1M | — | ||||||
| DocuSignCOM · shares −40% · price −5.1% | 1.6% | $69.7M | −$3.8M | ||||||
| Lattice SemiconductorCOM · shares New | 1.5% | $68.1M | — | ||||||
| Bloom EnergyCOM CL A · shares New | 1.4% | $64.3M | — | ||||||
| WabtecCOM · shares −0.8% · price +6.5% | 1.4% | $64.1M | +$3.9M | ||||||
| Roku IncCOM CL A · shares −29% · price +8.4% | 1.4% | $63.2M | +$4.9M | ||||||
| Total 62 positions | 100% | $4.49B | +$316.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2025 to Q4 2025: 32 stocks held throughout, up $316.2M (+14.2%).
- Natera Inc+$171.1M+42%
- Teva Pharmaceutical Inds Ltd+$64.7M+55%
- Insmed Inc+$44.5M+21%
- Woodward Inc+$29.3M+20%
- Cogent Biosciences Inc+$22.4M+147%
- Stubhub Hldgs Inc−$7.6M−20%
- Purecycle Technologies Inc−$10.5M−35%
- Sea−$14.0M−29%
- MercadoLibre−$15.2M−14%
- Coupang Inc−$39.9M−27%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |